H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) shares passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares.
H. Lundbeck A/S Stock Down 0.0 %
The company has a market capitalization of $21.91 billion, a PE ratio of 25.00 and a beta of 0.68. The company has a current ratio of 1.15, a quick ratio of 0.71 and a debt-to-equity ratio of 0.32. The business has a fifty day moving average of $22.00 and a 200 day moving average of $22.00.
H. Lundbeck A/S Company Profile
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
See Also
- Five stocks we like better than H. Lundbeck A/S
- What is the Shanghai Stock Exchange Composite Index?
- Energy Transfer: Powering Data With Dividends and Diversification
- Are Penny Stocks a Good Fit for Your Portfolio?
- Qualcomm Stock Is Coiling for a Breakout
- Short Selling: How to Short a Stock
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
